Viewing Study NCT00867932


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2025-12-31 @ 12:15 AM
Study NCT ID: NCT00867932
Status: COMPLETED
Last Update Posted: 2018-10-31
First Post: 2009-03-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH)
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M07-005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators